Table 1 Patient demographics and platelet-rich-plasma characteristics.

From: In vitro responses to platelet-rich-plasma are associated with variable clinical outcomes in patients with knee osteoarthritis

Demographics

Sex (male:female)

26:25

Age (years, mean ± s.d.)

57.92 ± 10.11

BMI (kg/m2, mean ± s.d.)

25.96 ± 4.07

Whole blood

Platelets (× 103/µl, mean ± s.d.)

226.30 ± 48.33

Leukocytes (× 103/µl mean ± s.d.)

6.53 ± 1.96

Platelet-Rich-Plasma

Kit

Arthrex, ACP

Time (minutes, mean ± s.d.)

4.3 ± 7.3

Vol prepared (ml, mean ± s.d.)

4.65 ± 0.22

Vol injected (ml, mean ± s.d.)

3.7 ± 0.7

Platelets (× 103/µl, mean ± s.d.)

361.40 ± 67.41

Leukocytes (× 103/µl, mean ± s.d.)

1.34 ± 0.81